20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3055 | Liensinine Perchlorate | Apoptosis , Others | |
Liensinine is the active constituent of plumula nelambinis with anti-hypertension. | |||
T8899 | Metipranolol | Adrenergic Receptor | |
Metipranolol (Betamann) is a type of β- Adrenergic receptors( β- A potent antagonist of adrenergic receptor on guinea pig atria β 1- Adrenergic receptors and rat uterus β The 2-adrenergic receptor exhibited the beta bloc... | |||
TN1416 | Ayanin | IL Receptor , P450 , PARP , PDE | |
Ayanin has vasorelaxant activity, it also may have the potential for use in treating allergic asthma.The IC(50) value of Ayanin (quercetin-3,7,4'-O-trimethylether) is 2.2microM for inhibiting interleukin (IL)-4 productio... | |||
T13865 | Resorcinolnaphthalein | RAAS | |
Resorcinolnaphthalein is a specific enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). | |||
T12268 | NTP42 | Prostaglandin Receptor , PPAR | |
NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM) | |||
T0114 | Trichlormethiazide | Naqua,Metahydrin,Trichlormetazid | ATPase , Carbonic Anhydrase |
Trichlormethiazide (Naqua) is a short-acting, 3-dichloromethyl derivative of hydrochlorothiazide, belonging to the class of thiazide diuretics. Trichlormethiazide appears to block the active reabsorption of chloride and ... | |||
T11339 | Furegrelate sodium | U-63557A | PPAR |
Furegrelate sodium (U-63557A) is a selective thromboxane synthase inhibitor with oral activity. Furegrelate sodium(U-63557A) inhibits thromboxane A2 (TXA2) synthase in human platelet microsomes with an IC50 of 15 nM. | |||
T1385 | Amlodipine | UK-48340 | Calcium Channel |
Amlodipine (UK-48340) is a synthetic dihydropyridine and a calcium channel blocker with antihypertensive and antianginal properties. | |||
T1484 | Perindoprilat | Perindoprilate | RAAS , MRP , AChR |
Perindoprilat (Perindoprilate) is an angiotensin-converting enzyme inhibitor. | |||
T8372 | VU0134992 | VU 0134992 | Potassium Channel |
VU0134992 is an Kir4.1 blocker with an IC50 value of 0.97 μM | |||
T4316 | ML365 | Potassium Channel | |
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3). | |||
T8900 | Seralutinib | GB002 | PDGFR |
Seralutinib (GB002) is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension. | |||
T14315 | AR-9281 | APAU | Epoxide Hydrolase |
AR-9281 (APAU) is a potent and selective inhibitor of soluble epoxide hydrolase (s-EH) potentially for the treatment of hypertension and type 2 diabetes | |||
T6595 | Moexipril hydrochloride | Moexipril HCl,RS-10085,SPM 925,CI-925 | Apoptosis , RAAS |
Moexipril hydrochloride (Moexipril HCl) is a potent orally active nonsulfhydrylangiotensin converting enzyme (ACE)inhibitor, used for the treatment of hypertension and congestive heart failure. | |||
T0231 | Amlodipine Besylate | Amlodipine benzenesulfonate | Calcium Channel |
Amlodipine Besylate(Amlodipine benzenesulfonate) is a long-lasting calcium channel blocker. | |||
T2561 | Macitentan | ACT-064992 | Apoptosis , Endothelin Receptor |
Macitentan (ACT-064992) is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH). | |||
T1489 | Fosinopril sodium | SQ28555 | RAAS |
Fosinopril sodium is a phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. | |||
T13316 | VU0134992 hydrochloride | Potassium Channel | |
VU0134992 hydrochloride is the first subtype-preferring, orally active and selective blocker of Kir4.1 potassium channel pore(IC50 : 0.97 µM). | |||
T0386L | Ropivacaine | LEA-103 HCl | Potassium Channel , Sodium Channel |
Ropivacaine (LEA-103 HCl) is a local anaesthetic drug belonging to the amino amide group. | |||
TP1929L1 | Saralasin acetate(34273-10-4 free base) | RAAS | |
Saralasin acetate is a Non-selective angiotensin II antagonist. |